Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Inflammatory cytokines at the summits of pathological signal cascades in brain diseases.
Carbon Monoxide and the Brain : Time to Rethink the Dogma.
Seizure characteristics in multiple sclerosis patients.
Multiple sclerosis and psychiatric disorders: Comorbidity and sibling risk in a nationwide Swedish cohort.
Immunological Mechanism of Action and Clinical Profile of Disease-Modifying Treatments in Multiple Sclerosis.
Longitudinal change detection: Inference on the diffusion tensor along white matter pathways.
Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.
Assessing the safety of biologic agents in patients with rheumatoid arthritis.
Small-molecule Klotho enhancers as novel treatment of neurodegeneration.
Identification of a Selective RORγ Ligand That Suppresses T(H)17 Cells and Stimulates T Regulatory Cells.
Footfall Placement Variability and Falls in Multiple Sclerosis.
Development of Activity-Related Muscle Fatigue during Robot-Mediated Upper Limb Rehabilitation Training in Persons with Multiple Sclerosis: A Pilot Trial.
Relevance of CD34+ Cells as a Reservoir for JC Virus in Patients With Multiple Sclerosis.
The burden of multiple sclerosis variants in continental Italians and Sardinians.
Quality of life and employment in persons with multiple sclerosis.
Downregulation of Sphingosine 1-Phosphate Receptor 1 Promotes the Switch from Tangential to Radial Migration in the OB.
Treatment strategies for multiple sclerosis: When to start, when to change, when to stop?
Development of a nanomaterial bio-screening platform for neurological applications.
[Multiple sclerosis, neuromyelitis optica and spasticity: control of specific symptoms and quality of life].
Morning serum melatonin values in multiple sclerosis: A biochemical evaluation.
Pathological Involvement of Astrocyte-Derived Lipocalin-2 in the Demyelinating Optic Neuritis.
Humoral-Targeted Immunotherapies in Multiple Sclerosis.
Adolescent-onset Krabbe disease with an initial diagnosis of multiple sclerosis and a novel mutation.
ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis.
Circulating CCR7+ICOS+ Memory T Follicular Helper Cells in Patients with Multiple Sclerosis.

Pages